BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15588506)

  • 21. The emerging role of angiogenesis inhibitors in hematologic malignancies.
    Giles FJ
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):23-9. PubMed ID: 12102577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenalidomide in lymphomas and chronic lymphocytic leukemia.
    Wiernik PH
    Expert Opin Pharmacother; 2013 Mar; 14(4):475-88. PubMed ID: 23356486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
    Dong X; Han ZC; Yang R
    Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant epithelial tumors and hematologic malignancy.
    Marković-Glamocak M; Sucić M; Ries S; Gjadrov-Kuvezdić K; Labar B
    Diagn Cytopathol; 2008 Oct; 36(10):710-4. PubMed ID: 18773444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in hematologic malignancies.
    Moehler TM; Ho AD; Goldschmidt H; Barlogie B
    Crit Rev Oncol Hematol; 2003 Mar; 45(3):227-44. PubMed ID: 12633837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hematopoietic growth factors in angiogenesis.
    Ribatti D; Vacca A; De Falco G; Ria R; Roncali L; Dammacco F
    Acta Haematol; 2001; 106(4):157-61. PubMed ID: 11815712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch-ing from T-cell to B-cell lymphoid malignancies.
    Mirandola L; Comi P; Cobos E; Kast WM; Chiriva-Internati M; Chiaramonte R
    Cancer Lett; 2011 Sep; 308(1):1-13. PubMed ID: 21652011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenic therapy in hematologic malignancies.
    Moehler TM; Hillengass J; Goldschmidt H; Ho AD
    Curr Pharm Des; 2004; 10(11):1221-34. PubMed ID: 15078137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interregulation of VEGF/R endostatin and MMP in the angiogenesis of hematologic malignancies--review].
    Zhang JD; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1145-50. PubMed ID: 16403301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
    Zhao HY; Chen YX
    Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
    Ke X; Yang Y; Zhao X; Wang L
    Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances of IMiDs in cancer therapy.
    Li S; Gill N; Lentzsch S
    Curr Opin Oncol; 2010 Nov; 22(6):579-85. PubMed ID: 20689431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New observations support the significance of angiogenesis in myeloma].
    Lundberg LG; Lerner R; Palmblad J
    Lakartidningen; 2001 Nov; 98(45):4985-90. PubMed ID: 11816901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells.
    Vacca A; Ribatti D
    Recent Results Cancer Res; 2011; 183():87-95. PubMed ID: 21509681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].
    Li J; Luo SK; Hong WD; Zhou ZH; Zou WY
    Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer: targeting metastasis and angiogenesis.
    Chu E
    Clin Colorectal Cancer; 2002 Feb; 1(4):200. PubMed ID: 12450417
    [No Abstract]   [Full Text] [Related]  

  • 38. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.
    Sari I; Altuntas F; Hacioglu S; Kocyigit I; Sevinc A; Sacar S; Deniz K; Alp E; Eser B; Yildiz O; Kaynar L; Unal A; Cetin M
    Am J Hematol; 2008 Apr; 83(4):334-9. PubMed ID: 18069671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantification and morphometric analysis of vascular structures in the bone marrow. A critical review].
    Kvasnicka HM; Thiele J
    Pathologe; 2002 Nov; 23(6):472-9. PubMed ID: 12436301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insect bite-like reaction in patients with hematologic malignant neoplasms.
    Barzilai A; Shpiro D; Goldberg I; Yacob-Hirsch Y; Diaz-Cascajo C; Meytes D; Schiby R; Amariglio N; Trau H
    Arch Dermatol; 1999 Dec; 135(12):1503-7. PubMed ID: 10606056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.